AD |
Alzheimer’s disease |
ALS |
Amyotrophic lateral sclerosis |
AMD |
Age-related macular degeneration |
AP-1 |
Activator protein 1 |
APE1/Ref-1 |
Apurinic/apyrimidinic endonuclease 1/reduction-oxidation factor 1 |
APX2009 |
(E)-N,N-diethyl-2-((3-methoxy-1,4-dihydronaphthalen-2-yl)methylene)pentanamide |
APX2014 |
(E)-N-methoxy-2-((3-methoxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl)methylene)pentanamide |
APX3330 |
(2E)-2-[(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)methyelene]-undecanoic acid |
ARE |
Antioxidant response element |
ARPE-19 |
Adult retinal pigment epithelium-19 |
AUC |
Area under the curve |
BER |
Base-excision repair |
BMI |
Body mass index |
CA9 |
Carbonic anhydrase 9 |
CBF/NF-Y |
CCAAT-binding factor |
CCL20 |
C-C motif chemokine ligand 20 |
CI |
Cell index |
CIPN |
Chemotherapy-induced peripheral neuropathy |
CNS |
Central nervous system |
CREB |
cAMP-responsive element (CRE)-binding protein |
CXCR4 |
CXC motif chemokine receptor 4 |
DME |
Diabetic macular edema |
DR |
Diabetic retinopathy |
ECFCs |
Erythroid-colony-forming unit cells |
ECM |
Extracellular matrix |
EMSA |
Electrophoretic mobility shift assay |
ERK |
Extracellular-signal-regulated kinase |
HEY-C2 |
Ovarian cancer cell line |
HIF-1 |
Hypoxia-inducible factor 1 |
HIF-1α |
Hypoxia-inducible factor 1 α subunit |
HIF-1β |
Hypoxia-inducible factor 1 β subunit |
HO-1 |
Heme oxygenase 1 |
HRECs |
Human retinal microvascular endothelial cells |
HSF-1 |
Heat shock factor 1 |
HUVEC |
Human umbilical vein endothelial cells |
ICAM-1 |
Intracellular adhesion molecule 1 |
IBD |
Inflammatory bowel disease |
IKK |
IκB kinase |
IL-1β |
Interleukin 1β |
IL-6 |
Interleukin 6 |
IL-8 |
Interleukin 8 |
IP |
Intraperitoneal |
IVT |
Intravitreal |
JAK/STAT |
Janus kinase/signal transducer and activator of transcription |
LC-MS/MS |
Liquid chromatography with tandem mass spectrometry |
L-CNV |
Laser-induced choroidal neovascularization |
MCP-1 |
Monocyte chemoattractant protein-1 |
MPP+ |
1-methyl-4-phenylpyridinium |
mtDNA |
Mitochondrial DNA |
MTF-1 |
Metal regulatory transcription factor 1 |
NF-κB |
Nuclear factor κ light-chain-enhancer of activated B cells |
NPDR |
Non-proliferative diabetic retinopathy |
NPM1 |
Nucleophosmin 1 |
Nrf1 |
Nuclear factor erythroid 2-related factor 1 |
Nrf2 |
Nuclear factor erythroid 2-related factor 2 |
nvAMD |
Neovascular age-related macular degeneration |
OCT |
Optical coherence tomography |
oxLDL |
Oxidized low density lipoprotein |
PBPK |
Physiological-based pharmacokinetic |
PD |
Parkinson’s disease |
PDAC |
Pancreatic ductal adenocarcinoma |
PDGF-B |
Platelet-derived growth factor subunit B |
PDR |
Proliferative diabetic retinopathy |
PI3K/Akt |
Phosphoinositide-3-kinase |
PEBP-2 |
Polyomavirus enhancer-binding protein 2 |
Rf/6a |
Macaque choroidal endothelial cell-like cell line |
ROP |
Retinopathy of prematurity |
ROS |
Reactive oxygen species |
RPE |
Retinal pigment epithelium |
RVECs |
Retinal vascular endothelial cells |
SKOV-3X |
Human ovarian cancer cell line |
STAT3 |
Signal transducer and activator of transcription 3 |
TF(s) |
Transcription factor(s) |
TNF-α |
Tumor necrosis factor alpha |
TUNEL |
Terminal deoxynucleotidyl transferase dUTP nick end labeling |
VEGF |
Vascular endothelial growth factor |
VE-PTP |
Vascular endothelial protein tyrosine phosphatase |
VHL |
Von Hippel–Lindau |
YY1 |
Ying yang-1 |